Perspective Therapeutics (CATX) Net Margin (2010 - 2023)
Perspective Therapeutics recorded quarterly Net Margin of 105.73% in Q4 2023, up 394.67% quarter-over-quarter from 35.88% in Q3 2023.
Perspective Therapeutics' Net Margin history runs 14 years deep, the most recent figure standing at 105.73% for Q4 2023.
- In Q4 2023, Net Margin changed N/A year-over-year to 105.73%; the TTM figure through Dec 2023 stood at 1476.84% (changed N/A YoY), while the FY2023 annual figure was 631.31%, changed N/A from the prior year.
- Net Margin came in at 105.73% for Q4 2023 at Perspective Therapeutics, up from 35.88% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 105.73% in Q4 2023 to a low of 236.92% in Q3 2022.
- A 5-year average of 54.04% and a median of 46.29% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin plunged 14944 bps in 2022 and soared 20104 bps in 2023, its largest moves.
- Perspective Therapeutics' Net Margin stood at 40.75% in 2019, then grew by 10 bps to 36.8% in 2020, then slumped by 55 bps to 56.96% in 2021, then tumbled by 316 bps to 236.92% in 2022, then soared by 145 bps to 105.73% in 2023.
- According to Business Quant data, Net Margin over the past three periods registered 105.73%, 35.88%, and 108.0% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 105.73% |
| Sep 30, 2023 | -35.88% |
| Jun 30, 2023 | -108.00% |
| Mar 31, 2023 | -80.11% |
| Sep 30, 2022 | -236.92% |
| Jun 30, 2022 | -82.95% |
| Mar 31, 2022 | -46.29% |
| Dec 31, 2021 | -56.96% |
| Sep 30, 2021 | -87.48% |
| Jun 30, 2021 | -39.15% |
| Mar 31, 2021 | -28.65% |
| Dec 31, 2020 | -36.80% |
| Sep 30, 2020 | -30.03% |
| Jun 30, 2020 | -52.26% |
| Mar 31, 2020 | -19.03% |
| Dec 31, 2019 | -40.75% |
| Sep 30, 2019 | -35.38% |
| Jun 30, 2019 | -57.07% |
| Mar 31, 2019 | -58.73% |
| Dec 31, 2018 | -74.37% |
| Sep 30, 2018 | -96.73% |
| Jun 30, 2018 | -147.29% |
| Mar 31, 2018 | -84.87% |
| Dec 31, 2017 | -95.44% |
| Sep 30, 2017 | -127.91% |
| Jun 30, 2017 | -135.62% |
| Mar 31, 2017 | -106.32% |
| Dec 31, 2016 | -141.25% |
| Sep 30, 2016 | -138.85% |
| Jun 30, 2016 | -106.07% |
| Mar 31, 2016 | -100.00% |
| Dec 31, 2015 | -110.51% |
| Sep 30, 2015 | -81.13% |
| Jun 30, 2015 | -77.39% |
| Mar 31, 2015 | -82.57% |
| Dec 31, 2014 | -85.36% |
| Sep 30, 2014 | -75.67% |
| Jun 30, 2014 | -176.98% |
| Mar 31, 2014 | -183.91% |
| Dec 31, 2013 | -85.65% |
| Sep 30, 2013 | -190.49% |
| Jun 30, 2013 | -80.21% |
| Mar 31, 2013 | -57.35% |
| Dec 31, 2012 | -118.61% |
| Sep 30, 2012 | -94.33% |
| Jun 30, 2012 | -92.07% |
| Mar 31, 2012 | -42.17% |
| Dec 31, 2011 | -51.39% |
| Sep 30, 2011 | -91.06% |
| Jun 30, 2011 | -56.89% |
| Mar 31, 2011 | -73.22% |
| Dec 31, 2010 | -18.53% |
| Sep 30, 2010 | -65.90% |